Despite repeated promises that the Pharmaceutical Benefit Scheme would not be on the table in negotiations about a Free Trade Agreement with the US, this NYT story says this is a key demand on the US side. Moreover

The [recently-passed] Medicare bill also requires the Bush administration to apprise Congress on progress toward opening Australia’s drug pricing system.

It’s increasingly clear that this game is not worth the candle.